Minimal residual disease (MRD) refers to the small number of myeloma cells that may remain after treatment and are not detectable using conventional response criteria. In multiple myeloma, MRD ...
Rheumatologist Dr Thomas Batty and haematologist Dr Emma Conway O'Brien describe a rational approach to investigating multifocal pain ...
Jaime Suarez-Londono, MD: Transplant for myeloma is very easy to give. On day 12 they engraft and they go home. Adverse events are not that [severe], and they get this progression-free survival [PFS] ...
CAR-T treatment landscape in multiple myeloma basically has changed dramatically over the past few years.
Asianet Newsable on MSN
Advanced therapies, second stem cell transplants improve myeloma survival
Hospitals are seeing success treating multiple myeloma with advanced therapies. Second autologous stem cell transplants, even ...
Hospitals are reporting significant success in treating multiple myeloma, with patients undergoing advanced therapies, ...
Abstract: Multiple Sclerosis (MS) is a chronic and autoimmune disease that causes lesions in the central nervous system. It is diagnosed based on accurate identification and segmentation of lesions in ...
Pharmacokinetics and Safety of Selumetinib Granule Formulation in Children With Symptomatic, Inoperable Neurofibromatosis Type 1-Related Plexiform Neurofibromas (SPRINKLE; phase I/II) For over half a ...
Abstract: Accurate delineation of multiple sclerosis lesions in brain MRI remains difficult due to small and diffuse pathology and inter rater variability. Spatial attention models often pool over ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results